Sanofi (SNY) Tax Rate Growth (3y) (2012 - 2026)

Sanofi (SNY) Tax Rate Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Sanofi	-	-	9.49 Bn

Historic Data

Download Data

Date	Value
Mar 31, 2026	35.00
Dec 31, 2025	-423.00
Sep 30, 2025	65.00
Jun 30, 2025	-54.00
Mar 31, 2025	-105.00
Dec 31, 2024	-184,055.00
Sep 30, 2024	27.00
Jun 30, 2024	36.00
Mar 31, 2024	316.00
Dec 31, 2023	4,457.00
Sep 30, 2023	59.00
Jun 30, 2023	327.00
Mar 31, 2023	50.00
Dec 31, 2022	457,624.00
Sep 30, 2022	-174.00
Jun 30, 2022	-355.00
Mar 31, 2022	-46.00
Dec 31, 2021	183,438.00
Sep 30, 2021	-126.00
Jun 30, 2021	-162.00